Arrow-right Camera
The Spokesman-Review Newspaper

The Spokesman-Review Newspaper The Spokesman-Review

Spokane, Washington  Est. May 19, 1883
Partly Cloudy Day 38° Partly Cloudy

Tag search results

Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.

Mariah McKay and Janna Williams: Chain pharmacy pricing unfair to consumers

If Walmart or CVS tried charging five times more than local grocers for bread, milk and bananas, their customers would promptly start buying locally. Yet a new report from the Consumers Union shows those same chains get away with pricing prescription drugs several times higher than local pharmacies. Researchers called more than 150 pharmacies in six metro regions for cost quotes on five commonly-prescribed drugs. They found the total cost of these drugs was dramatically lower at independent retailers ($107). Chain drug stores charged an average of $849 for the same five drugs, big-box discounters charged $527, and grocery chain pharmacies charged $565.

Editorial: Opioid crisis needs strong action

The Trump administration hasn’t mentioned money, but it’s going to take billions. Any plans to cut Medicaid will undermine a response to the opioid crisis.

New deals for drugs: No heart attack or your money back

Warranties and money-back guarantees, long used to entice buyers of products like hand tools and kitchen gadgets, are now being used to sell something more crucial: pricey new-generation drugs for diseases like rheumatoid arthritis and cancer.

Cherokee Nation sues drug firms, retailers for flooding communities with opioids

Lawyers for the Cherokee Nation opened a new line of attack against the pharmaceutical industry Thursday, filing a lawsuit in tribal court that accuses the nation’s six top drug distributors and pharmacies of flooding communities in Oklahoma with hundreds of millions of highly addictive pain pills.

For Pfizer, bigger as one may be better than smaller with two

For Pfizer, bigger is still better. By deciding not to split in two after a lengthy evaluation, a decision announced Monday, the New York-based drugmaker is keeping greater leverage with the health insurers and pharmacy benefit managers that have gained increasing power since it first considered a breakup years ago.

Medical marijuana reduces prescription drug use, study finds

Patients fill significantly fewer prescriptions for conditions like nausea and pain in states where medical marijuana is available, researchers reported Wednesday in one of the first studies to examine how medical cannabis might be affecting approved treatments.